Drug Product

We have a formulation R&D team of 1,500+ formulators & analytical scientists, providing formulation development from preclinical to commercial phase. Our integrated drug product R&D and manufacturing facilities around the world supports both oral solid and parenteral dosage forms with various packaging formats. 

Bioavailability enhancing technologies such as lipid nanoparticle and spray dried dispersion are also available from laboratory to production scale.

In 2023 alone, 1,000+ preclinical-phase III molecules were supported, 40+ late-phase NCEs were validated , and we supported 10 commercial products.

Drug Product Services

Parenteral

Analytical

Packaging, Labeling and Distribution

High Potency

Enabling Technology Platform

lipid nanoparticle

Lipid Nanoparticle
(LNP)

Spray Dried Dispersion

Spray Dried
Dispersion

hot melt extrusion

Hot Melt
Extrusion

Nano
Suspension

Nano
Suspension

liquid capsules

Liquid
Capsules

Why WuXi STA?

drug product thumb Drug Product
Speed
Expertise
Global Quality Standard
Robust Supply
Integrated
Enabling Tech
Dont edit
Speed

8-12 weeks for IND ready formulation, 4-6 weeks from GMP API received to phase I CTM released, technology transfer to release of PPQ completed in 6 months

Team

1,400+ formulators and analytical scientists

Global Quality Standard

One quality system across all sites approved by major regulatory agencies in the world

Robust Supply

4 sites in United States, Europe and China support large scale production.

Integrated Collaboration

Formulation R&D – early phase, late phase, commercial manufacturing and analytical & QC teams work closely to streamline your projects

Enabling Technology

Lipid Nanoparticle, Spray Dried Dispersion, Hot Melt Extrusion enable your fomrmulations with enhanced solubility.

Featured Service Packages

How can we help?

Oligonucleotide or Peptide Projects?

Scroll to Top
Please enable JavaScript in your browser to complete this form.
Checkboxes